Organizer(s): Heather Christofk, Christian Metallo and Alec KimmelmanDate: January 21 - 25, 2018
Location: Snowbird Resort, Snowbird, UT, USA
This conference brings together experts in the tumor metabolism field to discuss new concepts in the regulation and role of cancer metabolism in tumor growth, as well as strategies for targeting tumor metabolism for therapeutic benefit. However, even though research and knowledge have grown in this field, there still remain many questions to be answered such as what is the role of mitochondria in promotion of cancer metabolic phenotypes, how does the influence of the microenvironment contribute to tumor metabolism, and what is the impact of tumor metabolism on the epigenetic state of cancer cells? This Keystone Symposia meeting will address such areas. In addition, the meeting aims to:1) Discuss these gaps in knowledge surrounding the influence of mitochondria and microenvironment on tumor metabolism as well as the influence of cancer metabolism on epigenetics; 2) Explore different approaches for identifying promising tumor metabolism drug targets; 3) Evaluate the best ways to model and quantify tumor metabolism in vivo; and 4) Provide a conceptual framework to trainees and non-experts in the field on the regulation and role of tumor metabolism in cancer biology. Anticipated outcomes include generation of new ideas and scientific knowledge, promotion of new collaborations, and enhanced use of correct methodologies for measuring tumor metabolism. This symposium is the premier conference for learning about the most important unpublished data in the tumor metabolism field and is invaluable to enhance accelerated discovery and development of new therapeutic approaches to target cancer metabolism.
Scholarship Deadline: September 26 2017
Discounted Abstract Deadline: September 26 2017
Abstract Deadline: October 24 2017
Discounted Registration Deadline: November 27 2017
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Cancer Institute (NCI)
Grant No. 1R13CA221318-01
Funding for this conference was made possible (in part) by 1R13CA221318-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.